GCC 1057 - Phase I Safety and Pharmacokinetic Study of XRP6258 (Cabazitaxel) In Advanced Solid Tumor Patients With Varying Degrees of Hepatic Impairment
RTOG 0436/H-30259 - A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel , Cisplatin, and Radiation for Patients with Esophageal Cancer Who Are Treated Without Surgery
|
|